Patent · US Active

Anti-GITR antigen-binding proteins and methods of use thereof

US10988545B2 · kind B2 · utility

0Cited by

4References

11Claims

0Family size

Assignee

Potenza Therapeutics, Inc. · US

Inventors

Daniel Hicklin · Montclair, US
Cynthia Seidel-Dugan · Belmont, US
William Winston · Marlborough, US
Jose Andres SALMERON-GARCIA · Westminster, US
Heather Brodkin · Newton, US
Sonja Kleffel · Boston, US
Nels P. Nielson · Cambridge, US

Key dates

Filing date	Feb 20, 2018
Grant date	Apr 27, 2021
Priority date	—
Expiry date	Feb 20, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are antigen-binding proteins (ABPs) that selectively bind to GITR and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.